Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells

Blood

Volumn 91, Issue 2, 1998, Pages 630-640

  Lewis, Ian D ^a   McDiarmid, Louise A ^a   Samels, Leanne M ^a   To, L Bik ^a   Hughes, Timothy P ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; EOSINOPHILIA; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE;

EID: 0031982855     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.2.630     Document Type: Article

References (53)

1. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290, 1973
2. de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR: A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300:765, 1982
3. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G: Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93, 1984
4. Koeffler HP, Golde DW: Chronic myelogenous leukemia-new concepts. N Engl J Med 304:1201, 1981
5. Griffin JD: Management of chronic myelogenous leukemia. Semin Hematol 23:20, 1986
6. The Italian Cooperative Study Group on Chronic Myeloid Leukemia: Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 330:820, 1994
7. Eaves CJ, Eaves AC: Cell culture studies in CML. Clin Haematol 1:931, 1987
8. Udomsakdi C, Eaves CJ, Swolin B, Reid DS, Barnett MJ, Eaves AC: Rapid decline of chronic myeloid leukaemic cells in long-term culture due to a defect at the leukemic stem cell level. Proc Natl Acad Sci USA 89:6192, 1992
9. Coulombel L, Kalousek DK, Eaves CJ, Gupta CM, Eaves AC: Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. N Engl J Med 308:1493, 1983
10. + bone marrow cells. Blood 84:1473, 1994
11. Lewis ID, Haylock DN, Moore S, To LB, Hughes TP: Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemia. Leukemia 11:581, 1997
12. 1-negative progenitors in treated as well as newly diagnosed patients. Blood 63:1172, 1984
13. Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave P: BCR/ABL negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients. Blood 87:4770, 1996
14. Fialkow PJ, Martin PJ, Najfeld V, Penfold GK, Jacobson RJ, Hansen JA: Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood 58:158, 1981
15. Bedi A, Zehnbauer BA, Collector MI, Barber JP, Zicha MS, Sharkis SJ, Jones RJ: BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood 81:2898, 1993
16. - progenitor cells in chronic phase CML, but not in more advanced phase CML, are polyclonal. Blood 88:230a, 1996 (abstr, suppl 1)
17. Verfaillie CM, Miller WJ, Boylan K, McGlave PB: Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 79:1003, 1992
18. Leemhuis T, Leibowitz D, Cox G, Silver R, Srour EF, Tricot G, Hoffman R: Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow. Blood 81:801, 1993
19. Barnett MJ, Eaves CJ, Phillips GL, Kalousek DK, Klingemann H-J, Lansdorp PL, Reece DE, Shepherd JD, Shaw GJ, Eaves AC: Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture. Bone Marrow Transplant 4:345, 1989
20. Carlo-Stella C, Mangoni L, Piovani G, Almici C, Garau D, Caramatti C, Rizzoli V: In vitro marrow purging in chronic myeiogenous leukemia: Effect of mafosfamide and recombinant granulocyte-macrophage colony-stimulating factor. Bone Marrow Transplant 8:265, 1991
21. Szczylik C, Skorski T, Nicolaides NC, Manzella L, Malaguarnera L, Venturelli D, Gewirtz AM, Calabretta B: Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science 253:562, 1991
22. Wright L, Wilson SB, Milliken S, Biggs J, Kearney P: Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia. Exp Hematol 21:1714, 1993
23. Vormoor J, Lapidot T, Pflumio F, Risdon G, Patterson B, Broxmeyer HE, Dick JE: Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 83:2489, 1994
24. Heike Y, Ohira T, Takahashi M, Saijo N: Long-term human hematopoiesis in SCID-hu mice bearing transplanted fragments of adult bone and bone marrow cells. Blood 86:524, 1995
25. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE: Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137, 1992
26. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645, 1994
27. Terpstra W, Prins A, Visser T, Wognum B, Wagemaker G, Löwenberg B, Wielenga J: Conditions for engraftment of human acute myeloid leukemia (AML) in SCID mice. Leukemia 9:1573, 1995
28. Kamel-Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G, Freedman MH, Phillips RA, Dick JE: A model of human acute iymphoblastic leukemia in immune-deficient SCID mice. Science 246:1597, 1989
29. Sawyers CL, Gishizky ML, Quan S, Golde DW, Witte ON: Propagation of human blastic myeloid leukemias in the SCID mouse. Blood 79:2089, 1992
30. Skorski T, Nieborowska-Skorska M, Calabretta B: A model of Ph' chronic myeloid leukemia-blast crisis cell line growth in immunode-ficient SCID mice. Folia Histochem Cytobiol 30:91, 1992
31. Beran M, Pisa P, O'Brien S, Kurzrock R, Siciliano M, Cork A, Andersson BS, Kohli V, Kantarjian H: Biological properties and growth in SClD mice of a new myeiogenous leukemia cell line (KBM-5) derived from chronic myeiogenous leukemia in blast phase. Cancer Res 53:3603, 1993
32. Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M, Laraya P, Keating A, Eaves A, Lansdorp PM, Eaves CJ, Dick JE: Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87:1539, 1996
33. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, Leiter EH: Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154:180, 1995
34. Terstappen LWMM, Safford M, Loken MR: Flow cytometric analysis of human bone marrow III. Neutrophil maturation. Leukemia 4:657, 1990
35. Hardwick A, Law P, Mansour V, Kulcinski D, Ishizawa L, Gee A: Development of a large-scale immunomagnetic separation system for harvesting CD34-positive cells from bone marrow, in Wothington-White DA, Gee AP, Gross S (eds): Advances in Bone Marrow Purging and Processing. New York, NY, Wiley-Liss, 1992, p 583
36. White DL, Hutchins CJ, Haylock DN, Turczynowicz S, Bishop A, To LB, Hughes TP, Juttner CA: Direct analysis of FACS-sorted hemopoietic cell fractions using FISH. Biotechniques 18:818, 1995
37. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D: Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science 250:559, 1990
38. Lichter P, Tang CC, Call K, Hermanson G, Evans GA, Housman D, Ward DC: High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247:64, 1990
39. Andrews RG, Singer JW, Bernstein ID: Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 169:1721, 1989
40. Lowry PA, Shultz LD, Greiner DL, Hesselton RAM, Kittler ELW, Tiarks CY, Rao SS, Reilly J, Leif JH, Ramshaw H, Stewart FM, Quesenberry PJ: Improved engraftment of human cord blood cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients. Biol Blood Marrow Transplant 2:15, 1996
41. Pflumio F, Izac B, Katz A, Shultz LD, Vainchenker W, Coulombel L: Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 88:3731, 1996
42. Agarwal R, Doren S, Hicks B, Dunbar CE: Long-term culture of chronic myelogenous leukemia marow cells on stem cell factor-deficient stroma favours benign progenitors. Blood 85:1306, 1995
43. Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256, 1988
44. Hesselton RM, Greiner DL, Mordes JP, Rajan TV, Sullivan JL, Shultz LD: High levels of human peripheral blood mononuclear engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. J Infect Dis 172:974, 1995
45. Cashman JD, Lapidot T, Wang JCY, Doedens M, Shultz LD, Lansdorp P, Dick JE, Eaves CJ: Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 89:4307, 1997
46. +-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 90:85, 1997
47. Larochelle A, Vormoor J, Hanenberg H, Wang JCY, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I, Williams DA, Dick JE: Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 2:1329, 1996
48. Lapidot T, Granberger T, Vormoor J, Estrov Z, Kollet O, Bunin N, Zaizov R, Williams DE, Freedman MH: Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice. Blood 88:2655, 1996
49. Udomsakdi C, Eaves CJ, Lansdorp PM, Eaves AC: Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia. Blood 80:2522, 1992
50. Ramshaw HS, Rao SS, Crittenden RB, Peters SO, Weier H-U, Quesenberry PJ: Engraftment of bone marrow cells into normal unprepared hosts: Effects of 5-fluorouracil and cell cycle status. Blood 86:924, 1995
51. - hematopoietic stem cells. Blood 83:1515, 1994
52. Pappayanopoulou T, Craddock C, Nakamato B: The VLA4/ VCAV-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine progenitors between marrow and spleen. Proc Nat Acad Sci USA 92:9647, 1995
53. Lundell BI, McCarthy JB, Kovach NL, Verfaillie CM: Activation-dependent α5β1 integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells. Blood 87:2450, 1996